Work

A Phase IB/II Study of Lirilumab with Azacytidine in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Year: 2017

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.09.033

Authors: Naval Daver, Prajwal Boddu, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Courtney DiNardo, Marina Konopleva, Naveen Pemmaraju, Tapan Kadia, Nitin Jain, Sherry Pierce, Nawar Hussain, Jing Ning, Graciela Nogueras-Gonzalez, Sreyashi Basu, Jorge Cortes, Padmanee Sharma, Hagop Kantarjian

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2762458860

FWCI:

Cites:

Cited by:

Related to: 10